Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
Deadly shootings on Detroit's east side leave two dead, four injured, prompting police to unveil new measures to combat rising gun violence.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Charity rowing team mistaken for 'illegal migrants' by MP, leading to multiple interventions, but crew uses attention to highlight fundraising for motor neurone disease research.
Deadly shootings on Detroit's east side leave two dead, four injured, prompting police to unveil new measures to combat rising gun violence.